HIV (Human Immunodeficiency Virus)
71
12
17
17
Key Insights
Highlights
Success Rate
85% trial completion
Clinical Risk Assessment
Based on trial outcomes
High Risk
Score: 62/100
4.2%
3 terminated out of 71 trials
85.0%
-1.5% vs benchmark
8%
6 trials in Phase 3/4
12%
2 of 17 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 17 completed trials
Clinical Trials (71)
A Study to Evaluate the Use of Resmetirom in Participants With MASLD and HIV
Screening With Portable X-rays for Rapid Recognition of TB
Vaginal Estradiol vs Moisturizer to Improve Postmenopausal Vaginal Aging Symptoms and the Microbiome in Women Living With HIV
PNF RCT to Decrease Alcohol Use and Increase HIV Prevention
REINItiation of Antiretroviral Therapy Using Oral bicTegravir, emtrIcitAbine and Tenofovir alafenamidE
Disease Evolution and Risk Factors of AIDS-related Prevalent Cancers
Impact of Migration History and Social Conditions on the Immuno-virological Control of HIV in Migrants in France
Integrating Project YES! With WHO-Endorsed Mental Health Approaches Among Youth Living With HIV
Sleep Outcomes and Multidimensional Assessment With Antiretroviral Therapy in People Living With HIV on Dolutegravir- vs Doravirine-Based Regimens
Coronary Artery Calcium Score in HIV Mexican Population (The CACsHIVMex Study)
Comparison of Acceptance and Commitment Therapy and Cognitive Behavior Therapy: Managing Psychological Distress and Its Multifaceted Impact on Stigmatization, Psychological Wellbeing, Social Support and Treatment Adherence in HIV/AIDS Patients
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive Women Living With HIV in C1001P-CS7 Zimbabwe
Feasibility Study Comparing One vs Two Probes for Thermal Ablation Among Cervical Cancer Screen Positive WLWH in C1001P-CS9 South Africa
Multimorbidity and Polypharmacy in People With HIV vs. the General Population in the Basque Country
Lipidomic and Multi-Omics Profiling of Fatty Liver Disease in People With and Without HIV
Boosting Olfactory and Sensory Training Study (BOOST)
A Clinical Study Evaluating the Safety, Tolerability, and Effect on HIV Reservoir of Ibalizumab Combined With Chidamide (a Histone Deacetylase Inhibitor) in People Living With HIV
Guaranteed Income to Boost HIV Care Continuity and Suppression Post-Jail Release
Improving the HIV Care Continuum With mHealth Technology
Stimulant and Polysubstance Use, Inflammation, and Sex Effects on Myocardial Disease in HIV